www.fdanews.com/articles/75904-dynavax-files-75-mln-stock-shelf
DYNAVAX FILES $75 MLN STOCK SHELF
August 30, 2005
Drug maker Dynavax Technologies Corp. (DVAX.O: Quote, Profile, Research) may periodically sell up to $75 million in common stock according to a regulatory filing on Monday. The Berkeley, California-based company said it plans to use the proceeds for general corporate purposes research and development and acquisitions, according to the filing with the U.S. Securities and Exchange Commission. Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of the sale.